Global Hemato Oncology Testing Market by Products & Services (Assay Kits, Services), Cancer (Leukemia, Non-Hodgkin Lymphoma), Technology, End-User - Forecast 2024-2030

Report
194 Pages
March 2024
Region: Global
360iResearch™
ID: 4904518

The Hemato Oncology Testing Market size was estimated at USD 3.76 billion in 2023, USD 4.36 billion in 2024, and is expected to grow at a CAGR of 16.12% to reach USD 10.71 billion by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Hemato Oncology Testing Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Hemato Oncology Testing Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Hemato Oncology Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adaptive Biotechnologies Corporation, Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Danaher Corporation, Diatron Medical Instruments Limited, EKF Diagnostics Holdings PLC, F. Hoffmann-La Roche Ltd., HORIBA, Ltd., Icon PLC, Illumina, Inc., Mindray Bio-Medical Electronics Co., Ltd., Nihon Kohden Corporation, and Sanofi S.A.

Market Segmentation & Coverage

This research report categorizes the Hemato Oncology Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

Products & Services
- Assay Kits
- Services
Cancer
- Leukemia
- Non-Hodgkin Lymphoma
Technology
- IHC
- NGS
- PCR
End-User
- Clinical Laboratories
- Hospitals

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as

What is the market size and forecast of the Hemato Oncology Testing Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Hemato Oncology Testing Market?
What are the technology trends and regulatory frameworks in the Hemato Oncology Testing Market?
What is the market share of the leading vendors in the Hemato Oncology Testing Market?
Which modes and strategic moves are suitable for entering the Hemato Oncology Testing Market?

Additional Product Information:

Purchase of this report includes 1 year online access with quarterly updates
This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Hemato Oncology Testing Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of hematologic cancer globally
5.1.1.2. Rising awareness on personalized medicine among consumers
5.1.1.3. Rapid development of new assays with growing partnerships
5.1.2. Restraints
5.1.2.1. Lack of standard reimbursement policies
5.1.3. Opportunities
5.1.3.1. Emerging demand for advanced treatment options globally
5.1.3.2. Ongoing research and development for the introduction of new testing procedures
5.1.4. Challenges
5.1.4.1. Complicated regulatory framework results in delayed approval of tests
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Hemato Oncology Testing Market, by Products & Services

6.1. Introduction
6.2. Assay Kits
6.3. Services

7. Hemato Oncology Testing Market, by Cancer

7.1. Introduction
7.2. Leukemia
7.3. Non-Hodgkin Lymphoma

8. Hemato Oncology Testing Market, by Technology

8.1. Introduction
8.2. IHC
8.3. NGS
8.4. PCR

9. Hemato Oncology Testing Market, by End-User

9.1. Introduction
9.2. Clinical Laboratories
9.3. Hospitals

10. Americas Hemato Oncology Testing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific Hemato Oncology Testing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa Hemato Oncology Testing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

14.1. Key Company Profiles
14.1.1. Abbott Laboratories
14.1.2. Adaptive Biotechnologies Corporation
14.1.3. Bio-Rad Laboratories, Inc.
14.1.4. Boule Diagnostics AB
14.1.5. Danaher Corporation
14.1.6. Diatron Medical Instruments Limited
14.1.7. EKF Diagnostics Holdings PLC
14.1.8. F. Hoffmann-La Roche Ltd.
14.1.9. HORIBA, Ltd.
14.1.10. Icon PLC
14.1.11. Illumina, Inc.
14.1.12. Mindray Bio-Medical Electronics Co., Ltd.
14.1.13. Nihon Kohden Corporation
14.1.14. Sanofi S.A.
14.2. Key Product Portfolio

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing

List of Figures

FIGURE 1. HEMATO ONCOLOGY TESTING MARKET RESEARCH PROCESS
FIGURE 2. HEMATO ONCOLOGY TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. HEMATO ONCOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HEMATO ONCOLOGY TESTING MARKET DYNAMICS
FIGURE 7. HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2023 VS 2030 (%)
FIGURE 8. HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2023 VS 2030 (%)
FIGURE 10. HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 12. HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. HEMATO ONCOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 24. HEMATO ONCOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. HEMATO ONCOLOGY TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. HEMATO ONCOLOGY TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL HEMATO ONCOLOGY TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 6. HEMATO ONCOLOGY TESTING MARKET SIZE, BY ASSAY KITS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. HEMATO ONCOLOGY TESTING MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 9. HEMATO ONCOLOGY TESTING MARKET SIZE, BY LEUKEMIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. HEMATO ONCOLOGY TESTING MARKET SIZE, BY NON-HODGKIN LYMPHOMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 12. HEMATO ONCOLOGY TESTING MARKET SIZE, BY IHC, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. HEMATO ONCOLOGY TESTING MARKET SIZE, BY NGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. HEMATO ONCOLOGY TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 16. HEMATO ONCOLOGY TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. HEMATO ONCOLOGY TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 19. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 32. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 33. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 34. CANADA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 35. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 36. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 37. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. MEXICO HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 41. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. UNITED STATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 45. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 46. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. ASIA-PACIFIC HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. AUSTRALIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 50. AUSTRALIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 51. AUSTRALIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. AUSTRALIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. CHINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 54. CHINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 55. CHINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 56. CHINA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 57. INDIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 58. INDIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 59. INDIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 60. INDIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 61. INDONESIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 62. INDONESIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 63. INDONESIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. INDONESIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 65. JAPAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 66. JAPAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 67. JAPAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 68. JAPAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 69. MALAYSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 70. MALAYSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 71. MALAYSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 72. MALAYSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 73. PHILIPPINES HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 74. PHILIPPINES HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 75. PHILIPPINES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. PHILIPPINES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 77. SINGAPORE HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 78. SINGAPORE HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 79. SINGAPORE HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 80. SINGAPORE HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. SOUTH KOREA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 82. SOUTH KOREA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 83. SOUTH KOREA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 84. SOUTH KOREA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. TAIWAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 86. TAIWAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 87. TAIWAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 88. TAIWAN HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 89. THAILAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 90. THAILAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 91. THAILAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. THAILAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 93. VIETNAM HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 94. VIETNAM HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 95. VIETNAM HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 96. VIETNAM HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 102. DENMARK HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 103. DENMARK HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 104. DENMARK HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 105. DENMARK HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. EGYPT HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 107. EGYPT HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 108. EGYPT HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. EGYPT HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. FINLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 111. FINLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 112. FINLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. FINLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 114. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 115. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 116. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 117. FRANCE HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 119. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 120. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. GERMANY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 122. ISRAEL HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 123. ISRAEL HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 124. ISRAEL HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. ISRAEL HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 126. ITALY HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 127. ITALY HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 128. ITALY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 129. ITALY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. NETHERLANDS HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 131. NETHERLANDS HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 132. NETHERLANDS HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. NETHERLANDS HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 134. NIGERIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 138. NORWAY HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 139. NORWAY HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 140. NORWAY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 141. NORWAY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. POLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 143. POLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 144. POLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. POLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. QATAR HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 147. QATAR HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 148. QATAR HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. QATAR HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 150. RUSSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 151. RUSSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 152. RUSSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 153. RUSSIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 158. SOUTH AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 159. SOUTH AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 160. SOUTH AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 161. SOUTH AFRICA HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 162. SPAIN HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 163. SPAIN HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 164. SPAIN HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 165. SPAIN HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. SWEDEN HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 167. SWEDEN HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 168. SWEDEN HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 169. SWEDEN HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 170. SWITZERLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 171. SWITZERLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 172. SWITZERLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 173. SWITZERLAND HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 174. TURKEY HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 175. TURKEY HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 176. TURKEY HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 177. TURKEY HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 178. UNITED ARAB EMIRATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 179. UNITED ARAB EMIRATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 180. UNITED ARAB EMIRATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 181. UNITED ARAB EMIRATES HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 182. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY PRODUCTS & SERVICES, 2018-2030 (USD MILLION)
TABLE 183. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY CANCER, 2018-2030 (USD MILLION)
TABLE 184. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. UNITED KINGDOM HEMATO ONCOLOGY TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. HEMATO ONCOLOGY TESTING MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 187. HEMATO ONCOLOGY TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 188. HEMATO ONCOLOGY TESTING MARKET LICENSE & PRICING

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Abbott Laboratories
Adaptive Biotechnologies Corporation
Bio-Rad Laboratories, Inc.
Boule Diagnostics AB
Danaher Corporation
Diatron Medical Instruments Limited
EKF Diagnostics Holdings PLC
F. Hoffmann-La Roche Ltd.
HORIBA, Ltd.
Icon PLC
Illumina, Inc.
Mindray Bio-Medical Electronics Co., Ltd.
Nihon Kohden Corporation
Sanofi S.A.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	194
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 4.36 Billion
Forecasted Market Value ( USD ) by 2030	$ 10.71 Billion
Compound Annual Growth Rate	16.1%
Regions Covered	Global

PURCHASE OPTIONS

Single User License PDF, Excel And Online Access

1 - 5 User License PDF, Excel And Online Access

Enterprise License PDF, Excel And Online Access

need a quote ?

License	Properties	Price
SINGLE USER LICENSE PDF, Excel and Online Access	This is a single user license, allowing one user access to the product.	€3693EUR$3,939USD£3,119GBP
1 - 5 USER LICENSE PDF, Excel and Online Access	This is a 1-5 user license, allowing up to five users have access to the product.	€4640EUR$4,949USD£3,919GBP
ENTERPRISE LICENSE PDF, Excel and Online Access	This is an enterprise license, allowing all employees within your organization access to the product.	€6534EUR$6,969USD£5,518GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects

The report addresses key questions such as

Table of Contents

Companies Mentioned (Partial List)

Methodology

Table Information

Related Topics

Related Reports

Global Hemato Oncology Testing Market Innovations and Strategic Insights Report - Market Data, Trends, Market Potential, Competitive Analysis and Growth Forecasts (2024 to 2032)

Hemato Oncology Testing Market Report: Trends, Forecast and Competitive Analysis to 2030

Global Hemato Oncology Testing Market Analysis & Forecast to 2024-2034

Hemato Oncology Testing Global Market Report 2024

Hemato Oncology Testing Market - Global Industry Size, Share, Trends, Opportunity, & Forecast 2018-2028

About the Hemato Oncology Testing Market